Large-scale testing (Phase 3)Study completedNCT02544750
What this trial is testing
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Who this might be right for
Tuberous Sclerosis ComplexSeizures
Jazz Pharmaceuticals 199